KV

Katalin Varadi

BI Baxter International: 8 patents #213 of 2,334Top 10%
BS Baxter Healthcare Sa: 7 patents #135 of 1,132Top 15%
BI Baxalta Incorporated: 7 patents #17 of 230Top 8%
NT Nektar Therapeutics: 4 patents #65 of 250Top 30%
IA Immuno Aktiengesellschaft: 3 patents #18 of 75Top 25%
BG Baxter Innovations Gmbh: 1 patents #18 of 22Top 85%
BH Baxter Healthcare: 1 patents #9 of 68Top 15%
BA Baxter Aktiengesellschaft: 1 patents #45 of 86Top 55%
📍 Wien, AT: #72 of 3,624 inventorsTop 2%
Overall (All Time): #220,964 of 4,157,543Top 6%
20
Patents All Time

Issued Patents All Time

Showing 1–20 of 20 patents

Patent #TitleCo-InventorsDate
10900979 Methods for testing effectiveness of a von Willebrand factor used in treating von Willebrand disease (VWD) Hanspeter Rottensteiner, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2021-01-26
10209263 Methods of measuring adamts 13 activity Hanspeter Rottensteiner, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2019-02-19
9547016 Method and compositions for specifically detecting physiologically acceptable polymer molecules Peter Turecek, Juergen Siekmann, Alfred Weber, Herbert Gritsch, Susanne Vejda 2017-01-17
9493544 Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage Mary J. Bossard, Gayle Stephenson, Zhihao Fang, Harold Zappe, Stacy Mitchell +5 more 2016-11-15
9488651 Methods of measuring ADAMTS 13 activity Hanspeter Rottensteiner, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2016-11-08
9274122 Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation) Gerald Schrenk, Hanspeter Rottensteiner, Peter Turecek, Alfred Weber, Heinz Anderle +5 more 2016-03-01
9110085 Methods of testing effectiveness of a treatment for thromobotic thrombocytopenic purpura by measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor Hanspeter Rottensteiner, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2015-08-18
8735086 Kit for measuring the thrombin generation in a sample of a patient's blood or plasma Peter Turecek, Brigitte Keil, Sylvia Peyrer-Heimstaett, Hans-Peter Schwarz 2014-05-27
8623612 Method for testing treatment of ADAMTS13 deficiency Hanspeter Rottensteiner, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2014-01-07
8557534 Method and compositions for specifically detecting physiologically acceptable polymer molecules Peter Turecek, Juergen Siekmann, Alfred Weber, Herbert Gritsch, Susanne Vejda 2013-10-15
8415114 Methods of measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor and uses thereof Hanspeter Rottensteiner, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2013-04-09
8349800 Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage Mary J. Bossard, Gayle Stephenson, Zhihao Fang, Harold Zappe, Stacy Mitchell +5 more 2013-01-08
8133865 von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage Mary J. Bossard, Gayle Stephenson, Zhihao Fang, Harold Zappe, Stacy Mitchell +5 more 2012-03-13
8053561 Pegylated factor VIII Juergen Siekmann, Herbert Gritsch, Peter Turecek 2011-11-08
7683158 Pegylated factor VIII Juergen Siekmann, Herbert Gritsch, Peter Turecek 2010-03-23
7557188 Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide Hans-Peter Schwarz, Peter Turecek, Hendrik Coenraad Hemker, Suzette Beguin 2009-07-07
7005502 Pharmaceutical preparation comprising vWF propeptide Hans-Peter Schwarz, Peter Turecek, Hendrik Coenraad Hemker, Suzette Beguin 2006-02-28
5863896 Evaluation of substances for altering and for increasing APC response Jan Rosing, Guido Tans, Hans-Peter Schwarz 1999-01-26
5804181 Pharmaceutical preparation for the prevention and treatment of blood coagulation disorders Johann Eibl, Hans-Peter Schwarz 1998-09-08
5643739 Assay for determining sensitivity to activated protein C Hans-Peter Schwarz, Hartmut Lang, Berta Moritz 1997-07-01